Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SCYX
↓ PDF (Pro)SCYNEXIS Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ
$0.97
+2.65%today
MKT CAP
$77M
-5.8% · 1Y
Earnings History
+43.1%
+26.3%
+15.0%
+97.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$0.97
Low
$3.00
Analyst Mean
$4.19
High
$5.58
3 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-4.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+5482.6%
5y Revenue CAGR+59.4%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership2.0%
Institutional Ownership25.2%
Short % of Float1.54%
Days to Cover1.4d
1 Week-3.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ANGULO GONZALEZ DAVID | Chief Executive Officer | Buy | 108,695 | $0.89 | $0.10M | 2026-04-01 |
| ANGULO GONZALEZ DAVID | Chief Executive Officer | Stock | 391,333 | $0.00 | $0.00M | 2026-01-29 |
| SUKENICK SCOTT A. J.D. | Officer | Stock | 129,833 | $0.00 | $0.00M | 2026-01-29 |
| MACLEOD IVOR | Chief Financial Officer | Stock | 129,833 | $0.00 | $0.00M | 2026-01-29 |
| ANGULO GONZALEZ DAVID | Chief Executive Officer | Stock | 32,500 | $0.76 | $0.02M | 2025-10-17 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Avidity Partners Management, LP | institution | 2.62% | $0.00B | -37.87% | 2025-12-31 |
| Goldman Sachs Group Inc | institution | 2.50% | $0.00B | +100.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 2.22% | $0.00B | +0.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 1.44% | $0.00B | +0.00% | 2025-12-31 |
| Acadian Asset Management. LLC | institution | 0.73% | $0.00B | +39.97% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 0.57% | $0.00B | +7.10% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.48% | $0.00B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 0.42% | $0.00B | +0.00% | 2025-12-31 |
| AMH Equity Ltd. | institution | 0.31% | $0.00B | -5.80% | 2025-09-30 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.28% | $0.00B | -0.36% | 2026-02-28 |
| Yakira Capital Management, Inc. | institution | 0.24% | $0.00B | +0.00% | 2025-12-31 |
| Renaissance Technologies, LLC | institution | 0.22% | $0.00B | +0.80% | 2025-12-31 |
| Bridgeway Capital Management, LLC | institution | 0.21% | $0.00B | +0.00% | 2025-12-31 |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | fund | 0.16% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.08% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | fund | 0.07% | $0.00B | +3.01% | 2026-02-28 |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | fund | 0.05% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.03% | $0.00B | +0.00% | 2026-02-28 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| BIOA | $820M | - | - | - | - | -27.1% | 0% | 2.04 | 0.00% |
| ETON | $833M | 60 | - | 16.4 | - | - | - | - | 0.00% |
| PCRX | $937M | 58 | 193.0 | 7.0 | - | - | - | - | 0.00% |
| CRON | $990M | 5 | - | - | - | - | - | - | 0.00% |
| AMPH | $1.1B | 100 | 11.8 | 6.9 | - | - | - | - | 0.00% |
| XERS | $1.1B | 60 | 94.7 | 17.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SCYX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.